Third, it has now been recognized that M2 macrophages can be therapeutically exploited to treat obesity [45], but additional studies would be necessary to translate our current discoveries into clinical settings, particularly for the development of Kdm2a inhibitors with minimal side effect. This evidence concerns the gene KDM2A and obesity disorder.